
Ripca Pharmaceutical Private Limited
About Ripca Pharmaceutical Private Limited
Data last updated:
Ripca Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2022PTC072237.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saleem Malik Ansari and Rachna Vaish.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹59.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹53,423 (net margin 0.9%) and EBITDA of ₹85,656 (EBITDA margin 1.4%).
Ripca Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0049865).
Company details
CIN history
Ripca Pharmaceutical has one previous CIN (Corporate Identification Number): U24100GJ2022PTC129439. The current CIN is U24100MP2022PTC072237, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MP2022PTC072237 | Current |
| U24100GJ2022PTC129439 | Previous |
Recognitions & Rankings of Ripca Pharmaceutical
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0049865
Contact details
Ripca Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressEd – 200 Ground Floor, Scheme No 94 Ring Road, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ripca Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ripca Pharmaceutical Private Limited, buy the company report.
Financials of Ripca Pharmaceutical Private Limited
FY 2025 filings availableRipca Pharmaceutical Private Limited reported revenue of ₹59.22 Lakh (up 161% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 161% in the latest year. EBITDA rose 212% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹85,656 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹53,423 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.4% | ||
| Net Profit Margin | 0.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ripca Pharmaceutical Private Limited, buy the company report.
Board of directors of Ripca Pharmaceutical Private Limited
Ripca Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saleem Malik Ansari | Director | 20 Nov 2023 | 3 Years 0 Months | Current |
| Rachna Vaish Also directs: Lioness Healthcare Services LLP, Lioness Health Services LLP | Director | 17 Feb 2022 | 4 Years 9 Months | Current |
Peer comparison
Ripca Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xania Lifescience Private Limited | ₹59.42 Lakh (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Malik Perfume Private Limited | ₹59.39 Lakh (FY 2025) | -88.0% | Kannauj, Uttar Pradesh, India | |||
| Liladhar Biyani Saltpetre (India) Limited | ₹59.33 Lakh (FY 2025) | 36.0% | Rajasthan, India | |||
| Agatsya Aushadh Private Limited | ₹59.31 Lakh (FY 2024) | 89.0% | Bangalore, Karnataka, India | |||
| Ceramond India Private Limited | ₹59.3 Lakh (FY 2020) | 115.0% | Adarsh Nagar, New Delhi, Delhi, India | |||
| Ripca Pharmaceutical Private Limitedthis company | ₹59.22 Lakh (FY 2024) | ₹53,423 | 0.9% | 161.0% | Indore, Madhya Pradesh, India | |
| GHK Organics Private Limited | ₹59.16 Lakh (FY 2025) | 598.0% | Jhagadia, Gujarat, India | |||
| Super Petroleum Products Private Limited | ₹59.11 Lakh (FY 2025) | -25.0% | Thane, Maharashtra, India | |||
| Decro Colors Private Limited | ₹59.1 Lakh (FY 2024) | -52.0% | Ahmedabad, Gujarat, India | |||
| Chemotech Industries India Private Limited | ₹59.09 Lakh (FY 2023) | 36.0% | Dombivli, Maharashtra, India | |||
| Dandraua Dhaam Private Limited | ₹59.08 Lakh (FY 2025) | 89.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Ripca Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ripca Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ripca Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ripca Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ripca Pharmaceutical Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Saleem Malik Ansari ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Ripca Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2022 (4+ years old) and is registered under CIN U24100MP2022PTC072237.
Ripca Pharmaceutical has 2 current directors:
- Saleem Malik Ansari - Director
- Rachna Vaish - Director
The latest financial statements of Ripca Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ripca Pharmaceutical is U24100MP2022PTC072237. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ripca Pharmaceutical was incorporated on 17 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ripca Pharmaceutical by revenue are Xania Lifescience Private Limited, Malik Perfume Private Limited, Liladhar Biyani Saltpetre (India) Limited, Agatsya Aushadh Private Limited, Ceramond India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Saleem Malik Ansari ceased to be Additional Director on 29 Sep 2024. Kamlesh Rathore ceased to be Additional Director on 10 Jul 2024. Sangita ceased to be Director on 04 Mar 2024. Ripca Pharmaceutical has 6 board changes on record in total.
Yes, Ripca Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Ripca Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0049865).
The registered office of Ripca Pharmaceutical is at Ed – 200 Ground Floor, Scheme No 94 Ring Road, Indore, Madhya Pradesh, India – 452001.
Ripca Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

